Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Thursday, June 13, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 12, 2019 /PRNewswire/ -- Global Meningococcal Vaccines Market: OverviewThis report analyzes the current and future scenario of the global meningococcal vaccines market. Advancements in healthcare, increase in awareness and education through various non-profit organizations, and a rise in patient awareness and health care expenditure are key factors that

are projected to drive the global market during the forecast period.Read the full report: https://www.reportlinker.com/p03999775/?utm_source=PRN The global meningococcal vaccines market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market.It also provides information and data analysis of the global market with respect to the segments based on type, end-user, and region.A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section.Additionally, the section comprises a competitive matrix and company profiles along with business overview to understand the competitive landscape in the market.This section of the report also provides market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global meningococcal vaccines market.Global Meningococcal vaccines Market: Key SegmentsThe global meningococcal vaccines market has been segmented based on type, end-user, and region.In terms of type, the global market has been classified into polysaccharide vaccines, conjugate vaccines, combination vaccines, and Men B vaccines.The polysaccharide vaccines segment has been further sub-segmented into Menomune, Mencevax, NmVac4, and others.The conjugate vaccines segment has been further sub-segmented into Menactra, Menveo, NeisVac-C, Nimenrix, Meningitec, Menjugate, MenAfriVac, and NmVac4-DT.The combination vaccines segment has been further split into MenHibrix, and Menitorix.The Men B vaccines segment has been further sub-segmented into Bexsero, and Trumenba.Based on end-user, the market has been classified into retail pharmacies, hospital pharmacies, and others. Based on region, the global market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these segments have been provided for the period from 2017 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.Global Meningococcal vaccines Market: Regional OutlookIn terms of region, the global meningococcal vaccines market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, Israel, and rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2017 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.Companies Mentioned in the ReportThe report also profiles major players in the global meningococcal vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Sanofi SA, Novartis International, GlaxoSmithKline plc, Pfizer Inc., Nuron Biotech, JN-International Medical Corporation, Serum Institute of India Ltd., Baxter International, and Biomed Pvt. Ltd.The global meningococcal vaccines market has been segmented as below:Global Meningococcal Vaccines Market, by TypePolysaccharide VaccinesMenomuneMencevaxNmVac4OthersConjugate VaccinesMenactraMenveoNeisVac-CNimenrixMeningitecMenjugateMenAfriVacNmVac4-DTCombination VaccinesMenHibrixMenitorixMen B VaccinesBexseroTrumenbaGlobal Meningococcal Vaccines Market, by End-userRetail PharmaciesHospital PharmaciesOthersGlobal Meningococcal Vaccines Market, by RegionNorth AmericaU.S.CanadaEuropeGermanyU.K.ItalyFranceSpainRest of EuropeAsia PacificIndiaChinaJapanAustralia & New ZealandRest of Asia PacificLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & AfricaGCC CountriesSouth AfricaIsraelRest of Middle East & AfricaRead the full report: https://www.reportlinker.com/p03999775/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/meningococcal-vaccines-market---global-industry-analysis-size-share-growth-trends-and-forecast-2018---2026-300866831.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store